Orthofix Medical Inc. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Orthofix Medical Inc. (OFIX) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $256.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-05
- Orthofix Medical Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $169.00K, a 98.53% decline year-over-year.
- Orthofix Medical Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $87.00K, a 62.34% decline year-over-year.
- Orthofix Medical Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $69.00K, a 81.94% decline year-over-year.
- Orthofix Medical Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $502.00K, a 45.09% increase year-over-year.
- Orthofix Medical Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $12.26M, a 746.17% increase from fiscal 2024.
- Orthofix Medical Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $1.45M, a 91.32% decline from fiscal 2023.
- Orthofix Medical Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $16.69M, a 197.84% increase from fiscal 2022.
- Orthofix Medical Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $5.60M, a 851.27% increase from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $169.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $256.00K 10-Q · filed 2026-08-05 | $325.00K derived: sum of 3 quarters · filed 2026-08-05 | $827.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $87.00K 10-Q · filed 2026-05-05 | $156.00K derived: sum of 2 quarters · filed 2026-05-05 | $658.00K derived: sum of 3 quarters · filed 2026-05-05 | $12.12M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $571.00K derived: sum of 2 quarters · filed 2026-02-24 | $12.03M derived: sum of 3 quarters · filed 2026-08-05 | $12.26M 10-K · filed 2026-02-24 |
| 2025-09-30 | $502.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $11.96M derived: sum of 2 quarters · filed 2026-08-05 | $12.19M 10-Q · filed 2025-11-04 | $12.57M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $11.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $11.69M 10-Q · filed 2026-08-05 | $12.07M derived: sum of 3 quarters · filed 2026-08-05 | $12.42M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $231.00K 10-Q · filed 2026-05-05 | $613.00K derived: sum of 2 quarters · filed 2026-05-05 | $959.00K derived: sum of 3 quarters · filed 2026-05-05 | $1.22M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $382.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $728.00K derived: sum of 2 quarters · filed 2026-02-24 | $987.00K derived: sum of 3 quarters · filed 2026-02-24 | $1.45M 10-K · filed 2026-02-24 |
| 2024-09-30 | $346.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $605.00K derived: sum of 2 quarters · filed 2025-11-04 | $1.07M 10-Q · filed 2025-11-04 | $1.98M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $259.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $721.00K 10-Q · filed 2025-08-05 | $1.64M derived: sum of 3 quarters · filed 2026-02-24 | $2.04M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $462.00K 10-Q · filed 2025-05-06 | $1.38M derived: sum of 2 quarters · filed 2026-02-24 | $1.78M derived: sum of 3 quarters · filed 2026-02-24 | $1.83M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $917.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.32M derived: sum of 2 quarters · filed 2026-02-24 | $1.37M derived: sum of 3 quarters · filed 2026-02-24 | $16.69M 10-K · filed 2026-02-24 |
| 2023-09-30 | $403.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $455.00K derived: sum of 2 quarters · filed 2024-11-07 | $15.77M 10-Q · filed 2024-11-07 | $15.95M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $52.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $15.37M 10-Q · filed 2024-08-06 | $15.54M derived: sum of 3 quarters · filed 2025-02-25 | $16.38M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $15.32M 10-Q · filed 2024-05-07 | $15.49M derived: sum of 2 quarters · filed 2025-02-25 | $16.33M derived: sum of 3 quarters · filed 2025-02-25 | $16.45M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $174.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $1.01M derived: sum of 2 quarters · filed 2025-02-25 | $1.13M derived: sum of 3 quarters · filed 2025-02-25 | $5.60M 10-K · filed 2025-02-25 |
| 2022-09-30 | $837.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $959.00K derived: sum of 2 quarters · filed 2023-11-08 | $5.43M 10-Q · filed 2023-11-08 | $5.56M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | $122.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $4.59M 10-Q · filed 2023-08-08 | $4.72M derived: sum of 3 quarters · filed 2024-03-05 | $4.77M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | $4.47M 10-Q · filed 2023-05-09 | $4.60M derived: sum of 2 quarters · filed 2024-03-05 | $4.64M derived: sum of 3 quarters · filed 2024-03-05 | $4.81M derived: sum of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | $129.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $174.00K derived: sum of 2 quarters · filed 2024-03-05 | $341.00K derived: sum of 3 quarters · filed 2024-03-05 | $589.00K 10-K · filed 2024-03-05 |
| 2021-09-30 | $45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $212.00K derived: sum of 2 quarters · filed 2022-11-03 | $460.00K 10-Q · filed 2022-11-03 | $800.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | $167.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $415.00K 10-Q · filed 2022-08-05 | $755.00K derived: sum of 3 quarters · filed 2023-03-06 | $974.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | $248.00K 10-Q · filed 2022-05-06 | $588.00K derived: sum of 2 quarters · filed 2023-03-06 | $807.00K derived: sum of 3 quarters · filed 2023-03-06 | $932.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | $340.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $559.00K derived: sum of 2 quarters · filed 2023-03-06 | $684.00K derived: sum of 3 quarters · filed 2023-03-06 | $959.00K 10-K · filed 2023-03-06 |
| 2020-09-30 | $219.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $344.00K derived: sum of 2 quarters · filed 2021-11-05 | $619.00K 10-Q · filed 2021-11-05 | $899.00K derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $400.00K 10-Q · filed 2021-08-06 | $680.00K derived: sum of 3 quarters · filed 2022-02-25 | $916.00K derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $275.00K 10-Q · filed 2021-04-30 | $555.00K derived: sum of 2 quarters · filed 2022-02-25 | $791.00K derived: sum of 3 quarters · filed 2022-02-25 | $953.00K derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $280.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $516.00K derived: sum of 2 quarters · filed 2022-02-25 | $678.00K derived: sum of 3 quarters · filed 2022-02-25 | $878.00K 10-K · filed 2022-02-25 |
| 2019-09-30 | $236.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $398.00K derived: sum of 2 quarters · filed 2020-11-05 | $598.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $162.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $362.00K 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $200.00K 10-Q · filed 2020-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |